Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
SPT Labtech announces leadership team changes
SPT Labtech announces leadership team changes
Patrick Bennett, the former Group CEO, will assume the role of Chair of the board and continue to work with the wider team in executing the company’s commercial strategy
DeepMatter appointments Non-Executive Director
DeepMatter appointments Non-Executive Director
The company will seek to leverage his knowledge to further develop its data platforms and ensure they meet the needs of the pharmaceutical industry
Surfachem restructures its business unit
Surfachem restructures its business unit
Ori Biotech appoints senior management roles
Ori Biotech appoints senior management roles
Stuart Milne and Kevin Gordon will join the company as CTO and Chief Data & Operating Officer respectively
Ilya Pharma strengthens senior management
Ilya Pharma strengthens senior management
Pfizer veteran Sylvia McBrinn joins Board while Oskar Lund becomes CFO
ACG appoints two senior Design Heads
ACG appoints two senior Design Heads
Both join the company’s R&D facility in Germany
Stablepharma announces addition to advisory board
Stablepharma announces addition to advisory board
The company’s patented StablevaX technology is designed to thermally stabilise and deliver vaccines without the requirement for refrigeration
Peli BioThermal appoints VP of Global Services
Peli BioThermal appoints VP of Global Services
Since joining the Peli BioThermal team, Hyde has expanded the company’s Crēdo on Demand rental program by growing global drop points, service centres and network stations
BioAscent appoints two Associate Directors
BioAscent appoints two Associate Directors
Dr Angelo Pugliese and Dr McArthur will be working as Associate Director of in silico discovery and data analysis, and Associate Director of medicinal chemistry respectively
Follicum appoints Jonas Edelswärd as CFO
Follicum appoints Jonas Edelswärd as CFO
During the period July 2018 to June 2019, he was a board member of Follicum
Crescendo Biologics strengthens leadership team
Crescendo Biologics strengthens leadership team
Booth will be responsible for Crescendo’s financial strategy and reporting, as well as global investor relations
Thomas Fricke appointed Commercial Director of IMA Pharma
Thomas Fricke appointed Commercial Director of IMA Pharma
Fricke began his career with IMA in 1992 as Sales Manager at IMA Germany. He later led the same branch as MD
Metrion Biosciences appoints Non-Executive Director
Metrion Biosciences appoints Non-Executive Director
Keogh is a chartered accountant and civil engineer with more than 30 years’ experience of Senior Finance Management
Stablepharma appoints ex IQVIA & Pfizer executive as CEO
Stablepharma appoints ex IQVIA & Pfizer executive as CEO
Özgür has led more than 300 transactions with valuations of $100m-10bn+, working with private equity & venture capital investors
CellGenix appoints Daniel Spatz VP Sales, Marketing & Logistics
CellGenix appoints Daniel Spatz VP Sales, Marketing & Logistics
Spatz will also be joining the company's management team
SmartAnalyst appoints Sasha Richardson CEO
SmartAnalyst appoints Sasha Richardson CEO
SmartAnalyst focuses on supporting bio-pharma innovation by driving the pipeline and portfolio value of pharmaceutical and biotech companies
Previous
1
…
23
24
25
26
(current)
27
28
29
…
214
Next
Trending Articles
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
How strong leadership transforms regulatory and operational challenges
Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence
Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan
Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board
MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all